LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
NTRP
NextTrip, Inc.
There isn't enough reported data to score NTRP yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NTRP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
NTRP's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
NTRP PE Valuation
NTRP has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NTRP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect NTRP's losses to grow, with revenue growing. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
NTRP has the stronger earnings trend. Trailing diluted EPS is down 224% for LCID versus NTRP down 106%.
NTRP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | -$5.84 | +$17.22 |
| Q3 2024 | -$21.18 | -$10.08 |
| Q2 2024 | -$21.61 | -$7.68 |
| Q1 2024 | -$22.46 | -$6.53 |
| Q4 2023 | -$23.06 | -$6.29 |
| Q3 2023 | -$11.10 | +$6.93 |
| Q2 2023 | -$13.93 | +$4.50 |
| Q1 2023 | -$15.93 | +$1.70 |
NTRP is still losing money, but far less than before: $1.22 per share over the past year, against $107.40 at its worst in late 2019.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID has the edge over NTRP on profitability, with a higher operating margin.
NTRP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $546.7K | -28% |
| Q2 2026 | $1.5M | +946% |
| Q1 2026 | $1.6M | +1839% |
| Q4 2025 | $1.2M | +1508% |
| Q3 2025 | $757.6K | +390% |
| Q2 2025 | $138.8K | -26% |
| Q1 2025 | $83.5K | 0% |
| Q4 2024 | $74.6K | -64% |
NTRP's revenue is growing: $546,687 last quarter, down 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -607% | -184 points |
| Q2 2026 | -201% | +3141 points |
| Q1 2026 | -336% | +2321 points |
| Q4 2025 | -257% | +2119 points |
| Q3 2025 | -423% | +528 points |
| Q2 2025 | -3342% | -2308 points |
| Q1 2025 | -2657% | 0 points |
| Q4 2024 | -2376% | -1778 points |
NTRP's operating margin was −607% last quarter, down 184 points from the same quarter a year ago.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
NTRP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.5M | -530% |
| Q2 2026 | -$2.3M | -$1.3M |
| Q4 2025 | -$2M | -$797.8K |
| Q3 2025 | $572.4K | +$1.4M |
| Q2 2025 | -$1M | +$99.7K |
| Q4 2024 | -$1.2M | -$310.9K |
| Q3 2024 | -$810.2K | -$638.2K |
| Q2 2024 | -$1.1M | -$37K |
NTRP has burned cash in almost every quarter: −$9M over the past year, against −$2M the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over NTRP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
NTRP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +517K shares |
| 1 year | +125% | +8.2M shares |
| 3 years | +2675% | +14.3M shares |
| 5 years | +3708% | +14.4M shares |
NTRP has 15M diluted shares, up 125% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NTRP Net Leverage
NTRP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NTRP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 19.1 | Oversold |
NTRP's weekly RSI is 33 (neutral) and its Stochastic is 19 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
NTRP PE vs Consumer Cyclical Sector
NTRP has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
NTRP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.52 | 29% below |
| 20 week MA | $1.62 | 33% below |
| 50 week MA | $2.41 | 55% below |
| 100 week MA | $3.28 | 67% below |
| 200 week MA | $4.07 | 73% below |
NTRP is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
NTRP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $198.0 | $62.2 | -69% |
| 2021 | $62.2 | $38.4 | -38% |
| 2022 | $38.4 | $8.80 | -77% |
| 2023 | $8.80 | $3.02 | -66% |
| 2024 | $3.02 | $5.36 | +77% |
| 2025 | $5.36 | $3.68 | -31% |
| 2026 YTD | $3.68 | $1.08 | -71% |
NTRP has the edge over LCID on returns for 2026, with the stronger performance.